Pharmacies Limit Covid Vaccine Access Following FDA Rule Change
ByAinvest
Wednesday, Sep 3, 2025 11:04 am ET1min read
CVS--
CVS has paused vaccine services in Massachusetts, Nevada, and New Mexico due to state laws and regulations. In the remaining 16 states, CVS can administer the vaccine to eligible individuals with a prescription from an authorized provider. Walgreens, on the other hand, is prepared to offer the vaccine in states where permitted.
The FDA's decision reflects an ongoing shift toward targeted vaccination strategies, prioritizing populations at highest risk of hospitalization and death. This new approach may affect insurance coverage for those outside the designated high-risk groups, with a COVID-19 dose potentially costing up to $140 without insurance.
The new restrictions are expected to make it harder for many people, such as healthy children and healthy younger adults, to get a shot ahead of the expected winter COVID surge. The Centers for Disease Control and Prevention (CDC) is expected to weigh in soon with influential recommendations on who should get inoculated.
References:
[1] https://www.nbcnews.com/health/health-news/fda-approves-fall-covid-shots-new-restrictions-rfk-jr-rcna227569
[2] https://www.cbsnews.com/colorado/news/cvs-walgreens-limit-access-covid-vaccines-required-state-guidelines/
Pharmacies CVS and Walgreens are scaling back access to updated Covid vaccines in multiple states following the FDA's new guidelines. CVS has paused vaccine services in three states and limited access in 13 others, while Walgreens has halted vaccination appointments. The FDA's new rules restrict eligibility to seniors 65 and older and high-risk younger adults with certain health conditions. Pharmacies are adjusting their protocols to align with these restrictions.
Pharmacies CVS and Walgreens have scaled back access to updated COVID-19 vaccines in multiple states following new guidelines from the Food and Drug Administration (FDA). The FDA has restricted eligibility to seniors aged 65 and older and high-risk younger adults with certain health conditions.CVS has paused vaccine services in Massachusetts, Nevada, and New Mexico due to state laws and regulations. In the remaining 16 states, CVS can administer the vaccine to eligible individuals with a prescription from an authorized provider. Walgreens, on the other hand, is prepared to offer the vaccine in states where permitted.
The FDA's decision reflects an ongoing shift toward targeted vaccination strategies, prioritizing populations at highest risk of hospitalization and death. This new approach may affect insurance coverage for those outside the designated high-risk groups, with a COVID-19 dose potentially costing up to $140 without insurance.
The new restrictions are expected to make it harder for many people, such as healthy children and healthy younger adults, to get a shot ahead of the expected winter COVID surge. The Centers for Disease Control and Prevention (CDC) is expected to weigh in soon with influential recommendations on who should get inoculated.
References:
[1] https://www.nbcnews.com/health/health-news/fda-approves-fall-covid-shots-new-restrictions-rfk-jr-rcna227569
[2] https://www.cbsnews.com/colorado/news/cvs-walgreens-limit-access-covid-vaccines-required-state-guidelines/

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet